Summary
The product Testosterone Propionate 100 mg/ml, manufactured by PrimePharma, was analyzed to verify its composition and potency. The sample, identified by batch number PP1760, was submitted by the reseller Opitropin.EU and tested by Janoshik Analytical, a laboratory recognized for its expertise in pharmaceutical quality testing. The analysis confirmed the presence of Testosterone Propionate with a measured concentration of 107.88 mg/ml, exceeding the label claim by 7.88%. This variance indicates the product is slightly overdosed but within acceptable limits for quality and consistency.
The testing process was initiated on 2 May 2023, with the sample received on 11 May 2023, and the analysis completed on 15 May 2023. As this sample was submitted by a reseller, it offers insights into the product’s representation in the market. However, the possibility of selective batch submissions emphasizes the importance of independent validation to confirm broader product consistency. This report serves as an educational resource to promote transparency and harm reduction in anabolic steroid use.
Detailed Report
Product Overview
- Manufacturer: PrimePharma
- Product Name: Testosterone Propionate 100 mg/ml
- Active Ingredient: Testosterone Propionate
- Batch Number: PP1760
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #29396
- Testing Ordered: 2 May 2023
- Sample Received: 11 May 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 107.88 mg/ml
- Accuracy: 107.88% (7.88% above the label claim)
Verification Details:
- Verification URL: https://janoshik.com/tests/29396_XDXR8CU3VC42
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This test report was submitted and funded by Opitropin.EU, a reseller. Reseller-submitted samples can provide useful insights into products available on the market, but they warrant careful scrutiny. Resellers may, intentionally or unintentionally, select batches known to meet label claims for testing. Such practices could potentially misrepresent the consistency of all products being sold.
The findings indicate that this batch of Testosterone Propionate 100 mg/ml is slightly overdosed, exceeding its label claim by 7.88%. While this is a positive result for this particular sample, it may not necessarily reflect all products available to consumers. Independent third-party testing would add credibility by ensuring the accuracy and consistency of multiple batches from broader market representation. The transparency and reliability of Janoshik Analytical support the validity of this report, but further validation is always recommended.
Conclusion
The analysis demonstrates that Testosterone Propionate 100 mg/ml from PrimePharma exceeds its labeled specification, with a measured concentration of 107.88 mg/ml. While this overdosage is within acceptable quality limits, it highlights the importance of transparency in testing and the value of independent verification to ensure consistency across batches. This report provides educational insights and supports harm reduction efforts, helping consumers make informed decisions about anabolic steroid products.
Disclaimer: This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
